Real-world outcomes of elderly patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) treated with chimeric antigen receptor T-cell (CAR-T) therapy.

Lindsey Fitzgerald, Boyu Hu, Caron A. Jacobson et al.|Journal of Clinical Oncology|2020

Cited by 19